Ono Enters into New Collaboration Agreement with Merus N.V. (106KB)
(WorldNews Japan)

March 14, 2018 Ono Enters into New Collaboration Agreement with Merus N.V. Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director and CEO, Gyo Sagara; "ONO") announced today that it entered into a collaboration agreement with Merus N.V. (Utrecht, the Netherlands; Chief Executive Officer, Ton Logtenberg, Ph.D.; "Merus") focused on the development of human bispecific antibodies that bind to a combination of targets designed for the treatment of autoimmune diseases. In April 2014, ONO and Merus entered into a research and license agreement to jointly develop...